Main
About company
About company
PJSC "Technolog"
PJSC “Lekhim-Kharkiv”
Lekhim-Obukhiv LLC
UAB «LEKHIM-VILNIUS»
FP «LEKHIM» LLC
Safety and pharmacovigilance (Technolog)
Safety and pharmacovigilance (Kharkiv)
Partners
Production
Medicinal products
Veterinary products
Mineral water
PHARMACIES
Export
News
Contacts
News
ENG
РУС
УКР
/
News
Home
/
News
/
Notification about shares repurchase.
05 July, 2023
Press-release : The Group of Pharmaceutical Companies “Lekhim” has entered into a sublicense agreement with the Medicines Patent Pool (MPP) to produce a generic version of the oral antiviral drug encitrelvir for COVID-19.
29 March, 2021
On March 25, 2021, Group of Companies Lekhim delivered to Ukraine the first shipment of CoronaVac, COVID˗19 Vaccine, (manufactured by Sinovac Life Sciences Co., Ltd.)
20 July, 2020
The construction of manufacturing and storage facilities of the third manufacturing site of Lekhim-Obukhiv LLC continues
27 February, 2019
Amendment to the notification about shares repurchase.
30 January, 2019
Notification about shares repurchase.
All news
30 January, 2019
Notification about shares repurchase.
This information is intended for partners in the territory of Ukraine.
1 October 2018
Group of companies "Lekhim" won a lawsuit regarding cancellation of the state registration for medicinal product Renalgan-Biolek.
Previous news
27 February 2019
Amendment to the notification about shares repurchase.
Next news
